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Objectives: To evaluate the awareness of hyperlipidemia among university stu-
dents and university staff members and to identify respondent variables that affect 
hyperlipidemia knowledge level. MethOds: A survey was conducted to evaluate 
the awareness of hyperlipidemia among university students and faculty members. 
A validated questionnaire was used to assess knowledge of factors that are respon-
sible for hyperlipidemia, knowledge of food that was responsible for hyperlipidemia 
and the knowledge regarding hyperlipidemia medicine. Respondents variables were 
associated with their knowledge level and were evaluated through SPSS version 
20. Results: Of the 205 respondents, 91 (44.2%) were male and 114 (55.8%) were 
females with a mean age of 26.8 years (SD 0.6). One hundred and thirty (63.6%) of 
respondents were students whereas 75 (36.4%) respondents were university staff 
members. Almost half (49.5%) of respondents BMI was normal (18.5-22.5) followed 
by pre-obese (25.7%) and obese (12.1%). One hundred and forty three (69.4%) of 
respondents had adequate knowledge of factors responsible for hyperlipidemia, 190 
(92.2%) had adequate knowledge of food responsible for hyperlipidemia, however 
only 7 (3.4%) respondents had adequate knowledge of hyperlipidemia medicine 
(HMG CoA reductase inhibitors). Respondent gender (p 0.004), education level (p 
0.016) and occupation (p 0.001) had a statistically significant association with factors 
responsible for hyperlipidemia. Respondent’s race (p 0.012) had a significant asso-
ciation with knowledge of food responsible for hyperlipidemia. Similarly, patient 
gender (p 0.046) and occupation (p 0.041) had significant association with knowl-
edge of hyperlipidemia medicine. cOnclusiOns: Awareness of hyperlipidemia 
was adequate among university students and staff members however awareness 
of hyperlipidemia medicine was inadequate. Regular seminars and workshops can 
help create awareness among different aspect of hyperlipidemia.
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Objectives: Stroke is a leading public health problem in terms of mortality and 
economic burden in Korea. Anticoagulants are the mainstay for ischemic stroke 
prevention in atrial fibrillation (AF), but many patients have contraindications to 
these drugs. A number of catheter-based left atrial appendage occlusion (LAAO) 
devices devised to eliminate the major cause of thromboembolism in AF patients 
have been commercialized in Europe but are not yet available in Korea. The pur-
pose of this study is to perform a budget impact analysis of LAAO in patients with 
AF contraindicated to anticoagulation. Such analysis could help decision makers 
assign greater priority to stroke prevention in Korea. MethOds: A budget impact 
model (BIM) was developed based on the number of ischemic strokes and deaths 
prevented by LAAO. LAAO was compared to no stroke prevention since AF patients 
contraindicated to anticoagulation have no other alternatives. Sensitivity analyses 
on clinical and cost inputs were performed. Results: LAAO demonstrated a benefit 
in terms of ischemic strokes and mortality avoided. The BIM was most sensitive to 
the patients’ baseline stroke risk factors, the treatment effect of LAAO, the cost of 
stroke management and the cost of the LAAO procedure. For instance, in high stroke 
risk patients with CHADS2VASc score ≥ 6 one stroke can be avoided within five years 
by LAAO performed in just three patients. LAAO can become cost saving after three 
years post LAAO procedure assuming that the cost of LAAO procedure is approxi-
mately ₩15,000,000, the total cost of stroke defined as direct and indirect cost in the 
first year is approximately 31,000,000 and the total cost in each subsequent year is 
approximately 12,500,000. cOnclusiOns: This analysis highlights that LAAO can 
be a cost saving stroke prevention therapy in anticoagulation intolerant AF patients 
in medium to long term post LAAO procedure.
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Objectives: To examine the medical costs during the first and the 2nd year fol-
lowing the onset of cardiovascular diseases, i.e. myocardial infarction (MI), angina, 
stroke, coronary heart failure (CHF), or peripheral arterial disease (PAD). MethOds: 
The National Health Insurance Research Database (NHIRD), a nationwide popu-
lation-based claims database, was used in the study. Patients who hospitalized 
with the principal diagnosis code of 410 for MI, 413 for angina, 430-434 for stroke, 
or 428 for CHF, or who had outpatient visits with the principal diagnosis of 443.9 
for PAD during 2005-2009 were identified as study subjects. The initial date of the 
hospitalization/outpatient visit with the diagnosis code associated with each dis-
ease was defined as the index date. Patients who had outpatient visits or hos-
pitalization with diagnoses of MI, angina, stroke, CHF and PAD within five years 
before the index date were excluded, except for patients who had outpatient visits 
within two weeks prior to the index date. Patients who withdrew from the health 
insurance program during the first and the 2nd year after the index date were also 
excluded. The generalized linear model was used to estimate medical costs associ-
ated with cardiovascular diseases within 1st year and 2nd year after the index date. 
All costs were inflated to 2011 dollars by using the medical care component of the 
Consumer Price Index. Results: The 1st year average total medical costs associated 
with MI, angina, stroke, CHF, and PAD were NT$293,995, NT$60,305, NT$141,086, 
bisoprolol and nebivolol. This research was supported by Provincial Secretariat 
for Science and Technological Development, Autonomous Province of Vojvodina 
project No 114-451-3551/2013-01 and by Ministry of Science, Republic of Serbia, 
project no 41012.
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Objectives: Catheter-based renal denervation (RDN) has emerged as a new 
therapy option for patients with treatment resistant hypertension (TR-HTN). 
However, inconsistency in the definition and prevalence estimates of TR-HTN has 
the potential to cause confusion with regards to: (1) identifying patients who may 
be eligible for RDN; (2) therapeutic options before consideration for RDN; and (3) 
estimates of potential budget impact. The objective of this analysis is to provide an 
evidence-based estimate of the prevalence of severe TR-HTN to determine the RDN 
eligible patient population in Australia. MethOds: Based on published consensus 
guidelines criteria, severe treatment HTN was defined as SBP ≥ 160 mm Hg despite 
receiving 3 or more anti-HTN drugs including a diuretic. Published prevalence of 
Australians with treated HTN was combined with evidence extracted from the lit-
erature regarding HTN severity, medication usage and clinical trial exclusion rate 
to estimate the number of RDN eligible patients in Australia. Results: In the most 
recent published national assessment, the gross prevalence of HTN in Australia was 
estimated as 34%, with a treatment rate of 53%. The current analysis estimated the 
prevalence of severe TR-HTN amongst treated HTN to be 3.5%. When exclusion 
criteria for RDN were applied, the eligible population was estimated at 1.1% of 
those receiving treatment for HTN. cOnclusiOns: RDN eligible patients represent 
a small and discrete subset of all patients receiving HTN treatment and, when the 
consequences in this high risk population are considered, would represent a moder-
ate impact on government health budgets. In addition, applying standardised and 
clinically based RDN selection criteria may lead to increased scrutiny and improved 
clinical management in the broader pool of HTN patients – some of whom may 
achieve a sufficient reduction in SBP without the need for RDN.
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Objectives: Masked hypertension is associated with an increased risk for car-
diovascular conditions. The aim of the study was to evaluate the relationship 
obesity parameters, including body weight, waist circumference, body mass 
index. MethOds: The study group consisted of 118 consecutive patients with 
masked hypertension and 115 healthy control subjects. After a complete medical 
history and laboratory examination, patients’ height, weight, waist circumference 
heart rate, and office blood pressure were recorded. All subjects underwent ambula-
tory blood pressure monitoring. Masked hypertension is defined as normal office 
blood pressure measurement and high ambulatory blood pressure level. Results: 
Baseline characteristics in patients and controls were similar. Waist circumference 
(93.5±12.4 vs. 87.5±8.5, P< 0.001), weight (79.7±11.4 vs. 68.3±9.9, P< 0.001), body mass 
index (29.9±3.7 vs. 25.1±4.6, P< 0.001) in masked hypertensive subjects was signifi-
cantly higher than controls. cOnclusiOns: This study demonstrated that anthro-
pometric indices such as waist circumference, body mass index were higher in 
masked hypertensive patients. It can be suggested that predefining obesity might 
be helpful in early detection of masked hypertension.
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Objectives: There is considerable literature from developed nations on the effect 
of body mass index (BMI) on outcomes following cardiac surgery. Increased BMI is 
associated with an increased postoperative morbidity. World health organization 
(WHO) has suggested modified scale for Asians to categorize BMI. We have studied 
the effect of BMI on our population, using modified scale, as predictor of outcome 
after coronary artery bypass grafting (CABG). MethOds: 1019 charts of first time 
isolated elective CABG patients was retrospectively reviewed from January 2006 
to December 2008. We excluded patients undergoing urgent, emergency and off 
pump procedures. Data was analyzed on SPSS17. Logistic regression was applied 
to explore whether increased BMI is a predictor of in- hospital complications after 
CABG. Results: Retrospective analysis of 1019 first time isolated elective CABG 
patients was performed. Out of them, 163(16.0%) patients had normal BMI (18.5 to 
22.9 (kg/m2) while 856(84.0%) had increased BMI (≥ 23.0 (kg/m2). Operative profile 
shows that (888 (87.%)) patients had three vessels coronary artery disease and (970 
(95.2%)) got IMA grafts. Their 30-days mortality was 0.8%. The data showed patients 
with higher BMI tended to have increased postoperative complications. However 
multivariate analysis revealed age (adj OR: 1.04; 95%C.I: 1.02, 1.06), hospital stay (adj 
OR: 1.07; 95% C.I: 1.04, 1.10), perfusion time (adj OR: 1.48; 95%C.I: 1.05, 2.10) and renal 
failure (adj OR: 1.63; 95% C.I: 1.02, 2.59) as significantly associated with in hospital 
complications, while increased BMI remained insignificant at P value of ≤ 0.05. Model 
was adequately fit at P= 0.749 by Hosmer and Lemeshow test. cOnclusiOns: This 
study concludes that increased BMI in itself is not a predictor of increased mortal-
ity and morbidity. Post-operative complications in first time isolated elective CABG 
patients is, in fact, associated with increasing age, hospital stay, perfusion time 
and renal failure.
